NCT06490211 The Research Value of Multi-omics and Multi-modal Information in the Diagnosis and Treatment of Urinary System Tumors
| NCT ID | NCT06490211 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| Condition | Urinary System Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-11-20 |
| Primary Completion | 2026-11-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2023-11-20 with a primary completion date of 2026-11-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Obtain puncture or surgically removed tumor tissue samples from patients with urinary tract tumors and perform RNA-sequencing, Single-cell RNA-sequence, Spatial Transcriptomics, Proteomics, and Intratumoral Microbiome.
Eligibility Criteria
Inclusion Criteria: 1. Patients were treated for bladder cancer, kidney cancer, and prostate cancer in Wuhan Union Hospital from January 2024 to January 2026; 2. Aged \> 18 years old; 3. Urinalysis, urine exfoliated cells, ultrasound, CT, and MR examinations indicated the above tumors; 4. Tissue biopsy pathological examination confirmed the diagnosis of the above tumors. Exclusion Criteria: 1. Poor image quality; 2. Incomplete clinical data or loss of follow-up; 3. Presence of another primary malignant tumor other than urinary tract tumor; 4. Unclear pathological diagnosis
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06490211 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Urinary System Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06490211 currently recruiting?
Yes, NCT06490211 is actively recruiting participants. Contact the research team at yanglian@hust.edu.cn for enrollment information.
Where is the NCT06490211 trial being conducted?
This trial is being conducted at Wuhan, China.
Who is sponsoring the NCT06490211 clinical trial?
NCT06490211 is sponsored by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. The trial plans to enroll 100 participants.